Irisin/FNDC5 - An updated review

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 4, 2016, Pages 689-697

  Panati, K ^a,b   Suneetha, Y ^b   Narala, V R ^c  

^a Government College for Men (A)   (India)

^b SRI VENKATESWARA UNIVERSITY   (India)

^c YOGI VEMANA UNIVERSITY   (India)

Author keywords

Energy expenditure; FNDC5; Insulin resistance; Irisin; Obesity

Indexed keywords

FIBRONECTIN TYPE III DOMAIN CONTAINING 5 PROTEIN; HORMONE RECEPTOR; IRISIN; IRISIN RECEPTOR; MUSCLE PROTEIN; PROTEINASE; UNCLASSIFIED DRUG; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

AGING; ARTICLE; BROWN ADIPOSE TISSUE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; DISEASE COURSE; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; INSULIN RESISTANCE; KIDNEY DISEASE; METABOLIC DISORDER; METABOLIC REGULATION; NERVOUS SYSTEM DEVELOPMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; TELOMERE LENGTH; WHITE ADIPOSE TISSUE; ANIMAL; INFLAMMATION; METABOLISM; PATHOLOGY; SKELETAL MUSCLE;

ANIMALS; FIBRONECTINS; HUMANS; INFLAMMATION; MUSCLE, SKELETAL;

EID: 85017165695     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. NOCON M, HIEMANN T, MULLER-RIEMENSCHNEIDER F, THALAU F, ROLL S, WILLICH SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008; 15: 239-246.
2. TUOMILEHTO J, LINDSTROM J, ERIKSSON JG, VALLE TT, HAMALAINEN H, ILANNE-PARIKKA P, KEINANEN-KIUKAANNIEMI S, LAAKSO M, LOUHERANTA A, RASTAS M, SALMINEN V, UUSITUPA M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
3. PEDERSEN BK, FEBBRAIO MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012; 8: 457-465.
4. BORTOLUZZI S, SCANNAPIECO P, CESTARO A, DANIELI GA, SCHIAFFINO S. Computational reconstruction of the human skeletal muscle secretome. Proteins 2006; 62: 776-792.
5. PEDERSEN BK. Muscles and their myokines. J Exp Biol 2011; 214: 337-346.
6. SO B, KIM HJ, KIM J, SONG W. Exercise-induced myokines in health and metabolic diseases. Integr Med Res 2014; 3: 172-179.
7. PEDERSEN BK, AKERSTROM TC, NIELSEN AR, FISCHER CP. Role of myokines in exercise and metabolism. J Appl Physiol (1985) 2007; 103: 1093-1098.
8. BOSTROM P, WU J, JEDRYCHOWSKI MP, KORDE A, YE L, LO JC, RASBACH KA, BOSTROM EA, CHOI JH, LONG JZ, KAJIMURA S, ZINGARETTI MC, VIND BF, TU H, CINTI S, HOJLUND K, GYGI SP, SPIEGELMAN BM. A PGC1-alpha- dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-468.
9. DUN SL, LYU RM, CHEN YH, CHANG JK, LUO JJ, DUN NJ. Irisin-immunoreactivity in neural and nonneural cells of the rodent. Neurosci 2013; 240: 155-162.
10. ROBERTS MD, BAYLESS DS, COMPANY JM, JENKINS NT, PADILLA J, CHILDS TE, MARTIN JS, DALBO VJ, BOOTH FW, RECTOR RS, LAUGHLIN MH. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats. Metabolism 2013; 62: 1052-1056.
11. HUH JY, PANAGIOTOU G, MOUGIOS V, BRINKOETTER M, VAMVINI MT, SCHNEIDER BE, MANTZOROS CS. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012; 61: 1725-1738.
12. LECKER SH, ZAVIN A, CAO P, ARENA R, ALLSUP K, DANIELS KM, JOSEPH J, SCHULZE PC, FORMAN DE. Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail 2012; 5: 812-818.
13. SHARMA N, CASTORENA CM, CARTEE GD. Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines. Nutr Metab (Lond) 2012; 9: 90.
14. LIU JJ, WONG MD, TOY WC, TAN CS, LIU S, NG XW, TAVINTHARAN S, SUM CF, LIM SC. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 2013; 27: 365-369.
15. ROCA-RIVADA A, CASTELAO C, SENIN LL, LANDROVE MO, BALTAR J, BELEN CRUJEIRAS A, SEOANE LM, CASANUEVA FF, PARDO M. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013; 8: e60563.
16. MORENO-NAVARRETE JM, ORTEGA F, SERRANO M, GUERRA E, PARDO G, TINAHONES F, RICART W, FERNANDEZ-REAL JM. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013; 98: E769-778.
17. HUH JY, MOUGIOS V, SKRAPARLIS A, KABASAKALIS A, MANTZOROS CS. Irisin in response to acute and chronic whole-body vibration exercise in humans. Metabolism 2014; 63: 918-921.
18. AYDIN S, KULOGLU T, EREN MN, CELIK A, YILMAZ M, KALAYCI M, SAHIN I, GUNGOR O, GUREL A, OGETURK M, DABAK O. Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle. Peptides 2014; 52: 68-73.
19. PARK MJ, KIM DI, CHOI JH, HEO YR, PARK SH. New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro. Cell Signal 2015; 27: 1831-1839.
20. AYDIN S, KULOGLU T, YILMAZ M, KALAYCI M, SAHIN I, CICEK D. Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running. Peptides 2013; 50: 13-18.
21. TIMMONS JA, WENNMALM K, LARSSON O, WALDEN TB, LASSMANN T, PETROVIC N, HAMILTON DL, GIMENO RE, WAHLESTEDT C, BAAR K, NEDERGAARD J, CANNON B. Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A 2007; 104: 4401-4406.
22. VIRTANEN KA. BAT thermogenesis: Linking shivering to exercise. Cell Metab 2014; 19: 352-354.
23. LEAN ME. Brown adipose tissue in humans. Proc Nutr Soc 1989; 48: 243-256.
24. CANNON B, NEDERGAARD J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004; 84: 277-359.
25. NEDERGAARD J, BENGTSSON T, CANNON B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2007; 293: E444-452.
26. VIRTANEN KA, LIDELL ME, ORAVA J, HEGLIND M, WESTERGREN R, NIEMI T, TAITTONEN M, LAINE J, SAVISTO NJ, ENERBACK S, NUUTILA P. Functional brown adipose tissue in healthy adults. N Engl J Med 2009; 360: 1518-1525.
27. SEALE P, KAJIMURA S, SPIEGELMAN BM. Transcriptional control of brown adipocyte development and physiological function-of mice and men. Genes Dev 2009; 23: 788-797.
28. COUSIN B, CINTI S, MORRONI M, RAIMBAULT S, RICQUIER D, PENICAUD L, CASTEILLA L. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci 1992; 103: 931-942.
29. PETROVIC N, WALDEN TB, SHABALINA IG, TIMMONS JA, CANNON B, NEDERGAARD J. Chronic peroxisome prol i ferator -act ivated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 2010; 285: 7153-7164.
30. SHAN T, LIANG X, BI P, KUANG S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. FASEB J 2013; 27: 1981-1989.
31. ZHANG Y, LI R, MENG Y, LI S, DONELAN W, ZHAO Y, QI L, ZHANG M, WANG X, CUI T, YANG LJ, TANG D. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 2014; 63: 514-525.
32. POHER AL, ALTIRRIBA J, VEYRAT-DUREBEX C, ROHNERJEANRENAUD F. Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance. Front Physiol 2015; 6: 4.
33. KOMOLKA K, ALBRECHT E, SCHERING L, BRENMOEHL J, HOEFLICH A, MAAK S. Locus characterization and gene expression of bovine FNDC5: is the myokine irisin relevant in cattle? PLoS One 2014; 9: e88060.
34. FAIN JN, COMPANY JM, BOOTH FW, LAUGHLIN MH, PADILLA J, JENKINS NT, BAHOUTH SW, SACKS HS. Exercise training does not increase muscle FNDC5 protein or mRNA expression in pigs. Metabolism 2013; 62: 1503-1511.
35. STENGEL A, HOFMANN T, GOEBEL-STENGEL M, ELBELT U, KOBELT P, KLAPP BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 2013; 39: 125-130.
36. KURDIOVA T, BALAZ M, MAYER A, MADEROVA D, BELAN V, WOLFRUM C, UKROPEC J, UKROPCOVA B. Exercisemimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes. Peptides 2014; 56: 1-7.
37. RASCHKE S, ELSEN M, GASSENHUBER H, SOMMERFELD M, SCHWAHN U, BROCKMANN B, JUNG R, WISLOFF U, TJONNA AE, RAASTAD T, HALLEN J, NORHEIM F, DREVON CA, ROMACHO T, ECKARDT K, ECKEL J. Evidence against a beneficial effect of irisin in humans. PLoS One 2013; 8: e73680.
38. TIMMONS JA, BAAR K, DAVIDSEN PK, ATHERTON PJ. Is irisin a human exercise gene? Nature 2012; 488: E9-10.
39. NORHEIM F, LANGLEITE TM, HJORTH M, HOLEN T, KIELLAND A, STADHEIM HK, GULSETH HL, BIRKELAND KI, JENSEN J, DREVON CA. The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans. FEBS J 2014; 281: 739-749.
40. IVANOV IP, FIRTH AE, MICHEL AM, ATKINS JF, BARANOV PV. Identification of evolutionarily conserved non- AUG-initiated N-terminal extensions in human coding sequences. Nucleic Acids Res 2011; 39: 4220-4234.
41. HOFMANN T, ELBELT U, STENGEL A. Irisin as a musclederived hormone stimulating thermogenesis-a critical update. Peptides 2014; 54: 89-100.
42. VAN GREEVENBROEK MM, SCHALKWIJK CG, STEHOUWER CD. Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med 2013; 71: 174-187.
43. ZHANG M, CHEN P, CHEN S, SUN Q, ZENG QC, CHEN JY, LIU YX, CAO XH, REN M, WANG JK. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study. Eur Rev Med Pharmacol Sci 2014; 18: 1567-1572.
44. IIJIMA K, IIMURO S, SHINOZAKI T, OHASHI Y, SAKURAI T, UMEGAKI H, ARAKI A, OUCHI Y, ITO H. Lower physical activity is a strong predictor of cardiovascular events in elderly patients with type 2 diabetes mellitus beyond traditional risk factors: the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int 2012; 12: 77-87.
45. HANDSCHIN C, SPIEGELMAN BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008; 454: 463-469.
46. KIM JA, MONTAGNANI M, KOH KK, QUON MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113: 1888-1904.
47. XIANG L, XIANG G, YUE L, ZHANG J, ZHAO L. Circulating irisin levels are positively associated with endothelium- dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Atherosclerosis 2014; 235: 328-333.
48. EBERT T, FOCKE D, PETROFF D, WURST U, RICHTER J, BACHMANN A, LOSSNER U, KRALISCH S, KRATZSCH J, BEIGE J, BAST I, ANDERS M, BLUHER M, STUMVOLL M, FASSHAUER M. Serum levels of the myokine irisin in relation to metabolic and renal function. Eur J Endocrinol 2014; 170: 501-506.
49. CRUJEIRAS AB, PARDO M, CASANUEVA FF. Irisin: 'fat' or artefact. Clin Endocrinol (Oxf) 2015; 82: 467-474.
50. COLAIANNI G, CUSCITO C, MONGELLI T, PIGNATARO P, BUCCOLIERO C, LIU P, LU P, SARTINI L, DI COMITE M, MORI G, DI BENEDETTO A, BRUNETTI G, YUEN T, SUN L, RESELAND JE, COLUCCI S, NEW MI, ZAIDI M, CINTI S, GRANO M. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci U S A 2015; 112: 12157-12162.
51. CLARK PJ, BRZEZINSKA WJ, THOMAS MW, RYZHENKO NA, TOSHKOV SA, RHODES JS. Intact neurogenesis is required for benefits of exercise on spatial memory but not motor performance or contextual fear conditioning in C57BL/6J mice. Neurosci 2008; 155: 1048-1058.
52. CURLIK DM, 2ND, SHORS TJ. Training your brain: do mental and physical (MAP) training enhance cognition through the process of neurogenesis in the hippocampus? Neuropharmacology 2013; 64: 506-514.
53. MOON HS, DINCER F, MANTZOROS CS. Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism 2013; 62: 1131-1136.
54. WEINRICH SL, PRUZAN R, MA L, OUELLETTE M, TESMER VM, HOLT SE, BODNAR AG, LICHTSTEINER S, KIM NW, TRAGER JB, TAYLOR RD, CARLOS R, ANDREWS WH, WRIGHT WE, SHAY JW, HARLEY CB, MORIN GB. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997; 17: 498-502.
55. MATSUO T, SHIMOSE S, KUBO T, FUJIMORI J, YASUNAGA Y, SUGITA T, OCHI M. Correlation between p38 mitogen- activated protein kinase and human telomerase reverse transcriptase in sarcomas. J Exp Clin Cancer Res 2012; 31: 5.
56. RANA KS, ARIF M, HILL EJ, ALDRED S, NAGEL DA, NEVILL A, RANDEVA HS, BAILEY CJ, BELLARY S, BROWN JE. Plasma irisin levels predict telomere length in healthy adults. Age (Dordr) 2014; 36: 995-1001.
57. ERICKSON HP. Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor? Adipocyte 2013; 2: 289-293.
58. BOSTROM PA, FERNANDEZ-REAL JM. Metabolism: Irisin, the metabolic syndrome and follistatin in humans. Nat Rev Endocrinol 2014; 10: 11-12.
59. SCHUMACHER MA, CHINNAM N, OHASHI T, SHAH RS, ERICKSON HP. The structure of irisin reveals a novel intersubunit beta-sheet fibronectin type III (FNIII) dimer: implications for receptor activation. J Biol Chem 2013; 288: 33738-33744.
60. WANG S, MURA C, SAWAYA MR, CASCIO D, EISENBERG D. Structure of a Nudix protein from Pyrobaculum aerophilum reveals a dimer with two intersubunit beta-sheets. Acta Crystallogr D Biol Crystallogr 2002; 58 (Pt 4): 571-578.
61. WEN MS, WANG CY, LIN SL, HUNG KC. Decrease in irisin in patients with chronic kidney disease. PLoS One 2013; 8: e64025.
62. LEE P, LINDERMAN JD, SMITH S, BRYCHTA RJ, WANG J, IDELSON C, PERRON RM, WERNER CD, PHAN GQ, KAMMULA US, KEBEBEW E, PACAK K, CHEN KY, CELI FS. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab 2014; 19: 302-309.